Ultimately, this work identified a novel susceptibility of glioblastoma cells to TNFR1-dependent apoptosis, dependent on inhibition of canonical NFκB signalling using our previously reported palbociclib-HMCD conjugate, 1 [23]. Here, TNFRSF1A is linked to glioblastoma.